Medical induction of active Crohn's ileitis: evidence-based management.
Novak
Kerri
K
Division of Gastroenterology, Department of Medicine, University of Calgary, Alberta, Canada.
Sutherland
Lloyd
L
Panaccione
Remo
R
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000517:prevention & control / Q000628:therapy*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007079:Ileitis / Q000517:prevention & control / Q000628:therapy*; D011237:Predictive Value of Tests; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents